1. Potential for immunotherapy in soft tissue sarcoma
   William W Tseng et al, 2014, Human Vaccines & Immunotherapeutics CrossRef
2. Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
   Nguyen Thanh Liem et al, 2019, International Journal of Molecular Sciences CrossRef
3. Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma
   Long Jiang et al, 2015, Oncotarget CrossRef
4. Immunotherapies For Cancer, a Promising Cure?
   Xinlan Yang, 2020, Proceedings of the 1st International Symposium on Artificial Intelligence in Medical Sciences CrossRef
5. Translational Aspects of Epithelioid Sarcoma: Current Consensus
   Thomas G.P. Grünewald et al, 2024, Clinical Cancer Research CrossRef
6. Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells
   Xuewen Deng et al, 2014, International Immunopharmacology CrossRef
7. Immunotherapies in sarcoma: Updates and future perspectives
   Marwan Ghosn et al, 2017, World Journal of Clinical Oncology CrossRef
8. Cellular Immunotherapy for Sarcomas
   Seth M. Pollack et al, 2019, Immunotherapy of Sarcoma CrossRef
9. Current Immunotherapies for Sarcoma: Clinical Trials and Rationale
   Demytra Mitsis et al, 2016, Sarcoma CrossRef